-
Product Insights
NewLow Affinity Immunoglobulin Gamma Fc Region Receptor II-b – Drugs In Development, 2024
The Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b pipeline drugs market research report outlays comprehensive information on the Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Undisclosed, and Respiratory which include indications of Autoimmune Disorders, Systemic Lupus Erythematosus, Solid Tumor, Lymphoma, Unspecified, and Allergic Asthma. It...
-
Product Insights
NewNeprilysin – Drugs In Development, 2024
The Neprilysin pipeline drugs market research report outlays comprehensive information on the Neprilysin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Oncology, and Ophthalmology which include indications of Congestive Heart Failure (Heart Failure), Systolic Heart Failure, Post-Operative Pain, Ocular Pain (Eye Pain), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), and Keratoconjunctivitis Sicca...
-
Product Insights
NewBromodomain Testis Specific Protein – Drugs In Development, 2024
The Bromodomain Testis Specific Protein pipeline drugs market research report outlays comprehensive information on the Bromodomain Testis Specific Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Immunology, and Ophthalmology which include indications of Solid Tumor, Diffuse Large B-Cell Lymphoma, Idiopathic Pulmonary Fibrosis, Rheumatoid Arthritis, Inflammation, and Macular Degeneration. It also reviews key players involved...
-
Product Insights
NewSodium/Bile Acid Cotransporter – Drugs In Development, 2024
The Sodium/Bile Acid Cotransporter pipeline drugs market research report outlays comprehensive information on the Sodium/Bile Acid Cotransporter targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Gastrointestinal, Metabolic Disorders, and Undisclosed which include indications of Hepatitis B, Hepatitis D, Primary Sclerosing Cholangitis, Cholestasis, Unspecified Metabolic Disorders, and Unspecified. It also reviews key players involved in Sodium/Bile...
-
Product Insights
NewHistone Lysine N Methyltransferase EZH1 – Drugs In Development, 2024
The Histone Lysine N Methyltransferase EZH1 pipeline drugs market research report outlays comprehensive information on the Histone Lysine N Methyltransferase EZH1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Diffuse Large B-Cell Lymphoma, Solid Tumor, and Respiratory Syncytial Virus (RSV) Infections. It also reviews key players involved in Histone...
-
Product Insights
NewB Lymphocyte Antigen CD19 – Drugs In Development, 2024
The B Lymphocyte Antigen CD19 pipeline drugs market research report outlays comprehensive information on the B Lymphocyte Antigen CD19 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Undisclosed, and Hematological Disorders which include indications of B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), Diffuse Large B-Cell Lymphoma, Autoimmune Disorders, Systemic Lupus Erythematosus, Unspecified, Acquired (Autoimmune)...
-
Product Insights
NewSerine/Threonine Protein Kinase B Raf – Drugs In Development, 2024
The Serine/Threonine Protein Kinase B Raf pipeline drugs market research report outlays comprehensive information on the Serine/Threonine Protein Kinase B Raf targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Genetic Disorders, Non Malignant Disorders, and Dermatology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis), Kabuki Syndrome,...
-
Product Insights
NewToll Like Receptor 8 – Drugs In Development, 2024
The Toll Like Receptor 8 pipeline drugs market research report outlays comprehensive information on the Toll Like Receptor 8 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Musculoskeletal Disorders which include indications of Solid Tumor, Melanoma, Systemic Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus (SCLE), Hepatitis B, Human Immunodeficiency Virus (HIV) Infections (AIDS),...
-
Product Insights
NewCoagulation Factor IX – Drugs In Development, 2024
The Coagulation Factor IX pipeline drugs market research report outlays comprehensive information on the Coagulation Factor IX targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Metabolic Disorders, Other Diseases, and Central Nervous System which include indications of Hemophilia B (Factor IX Deficiency), Hemophilia A (Factor VIII Deficiency), Fabry Disease, Methylmalonic Acidemia, Trauma, and Brain Hemorrhage....
-
Product Insights
NewFc Fragment Of IgG Low Affinity III Receptor – Drugs In Development, 2024
The Fc Fragment Of IgG Low Affinity III Receptor pipeline drugs market research report outlays comprehensive information on the Fc Fragment Of IgG Low Affinity III Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Infectious Disease, and Immunology which include indications of Solid Tumor, Non-Small Cell Lung Cancer, Human Immunodeficiency Virus (HIV) Infections (AIDS), Hepatitis...